Joseph A Kaufman

Array ( [id] => 5131578 [patent_doc_number] => 20070207975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Materials and methods for treating and preventing Her-2/neu overexpressing, FAS-elevated cancer cells' [patent_app_type] => utility [patent_app_number] => 11/651803 [patent_app_country] => US [patent_app_date] => 2007-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22559 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207975.pdf [firstpage_image] =>[orig_patent_app_number] => 11651803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529820 [patent_doc_number] => 20100015214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Novel Trans-Adjuvant System' [patent_app_type] => utility [patent_app_number] => 12/086315 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11936 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015214.pdf [firstpage_image] =>[orig_patent_app_number] => 12086315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040227 [patent_doc_number] => 20070092509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Method for ex-vivo separation of apoptotic chromatin fragments from blood or plasma for prevention and treatment of diverse human diseases' [patent_app_type] => utility [patent_app_number] => 11/588446 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19974 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092509.pdf [firstpage_image] =>[orig_patent_app_number] => 11588446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146538 [patent_doc_number] => 08163543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'AAV vectors produced in insect cells' [patent_app_type] => utility [patent_app_number] => 12/091022 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9220 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163543.pdf [firstpage_image] =>[orig_patent_app_number] => 12091022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051387 [patent_doc_number] => 20070031932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom' [patent_app_type] => utility [patent_app_number] => 11/544490 [patent_app_country] => US [patent_app_date] => 2006-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11084 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031932.pdf [firstpage_image] =>[orig_patent_app_number] => 11544490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859670 [patent_doc_number] => 20080268520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR RECOMBINATIONAL CLONING OF NUCLEIC ACID MOLECULES' [patent_app_type] => utility [patent_app_number] => 11/539556 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25934 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20080268520.pdf [firstpage_image] =>[orig_patent_app_number] => 11539556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11177973 [patent_doc_number] => 09409959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => 'Silk proteins' [patent_app_type] => utility [patent_app_number] => 12/089045 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 14 [patent_no_of_words] => 27140 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12089045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5135662 [patent_doc_number] => 20070077291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'DRUG DELIVERY NANOCARRIERS TARGETED BY LANDSCAPE PHAGE' [patent_app_type] => utility [patent_app_number] => 11/536844 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6323 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077291.pdf [firstpage_image] =>[orig_patent_app_number] => 11536844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5080259 [patent_doc_number] => 20070123483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Method and composition for treating obesity by targeting cathespin' [patent_app_type] => utility [patent_app_number] => 11/526221 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19892 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123483.pdf [firstpage_image] =>[orig_patent_app_number] => 11526221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7534806 [patent_doc_number] => 08048428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/507298 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 17 [patent_no_of_words] => 13219 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048428.pdf [firstpage_image] =>[orig_patent_app_number] => 11507298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102273 [patent_doc_number] => 07723076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Use of selective labeling to detect and characterize molecular interactions by nuclear magnetic resonance spectroscopy' [patent_app_type] => utility [patent_app_number] => 11/504133 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5232 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723076.pdf [firstpage_image] =>[orig_patent_app_number] => 11504133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599009 [patent_doc_number] => 07977042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Composition and method for the restoration and preservation of transplant organs procured from DCD donors' [patent_app_type] => utility [patent_app_number] => 11/460261 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4087 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977042.pdf [firstpage_image] =>[orig_patent_app_number] => 11460261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5036922 [patent_doc_number] => 20070101461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Method for Improving Phytoremediation Treatment of a Contaminated Medium' [patent_app_type] => utility [patent_app_number] => 11/459866 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16980 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20070101461.pdf [firstpage_image] =>[orig_patent_app_number] => 11459866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 817250 [patent_doc_number] => 07411058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Cold-adapted equine influenza viruses' [patent_app_type] => utility [patent_app_number] => 11/438845 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14514 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/411/07411058.pdf [firstpage_image] =>[orig_patent_app_number] => 11438845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515565 [patent_doc_number] => 20090215872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Methods for Controlling Stem Cell Differentiation' [patent_app_type] => utility [patent_app_number] => 11/988321 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 125 [patent_no_of_words] => 41389 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11988321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074869 [patent_doc_number] => 20070014844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine' [patent_app_type] => utility [patent_app_number] => 11/475250 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18180 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014844.pdf [firstpage_image] =>[orig_patent_app_number] => 11475250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602925 [patent_doc_number] => 20060293270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Methods and compositions for treating ocular disorders' [patent_app_type] => utility [patent_app_number] => 11/472761 [patent_app_country] => US [patent_app_date] => 2006-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5805 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293270.pdf [firstpage_image] =>[orig_patent_app_number] => 11472761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315491 [patent_doc_number] => 20090280089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Inhibition of the liver tropism of adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 12/305331 [patent_app_country] => US [patent_app_date] => 2006-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2270 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280089.pdf [firstpage_image] =>[orig_patent_app_number] => 12305331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10013087 [patent_doc_number] => 09056090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-16 [patent_title] => 'Hepatitis C virus nucleic acid vaccine' [patent_app_type] => utility [patent_app_number] => 11/922309 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 53 [patent_no_of_words] => 13951 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11922309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5601776 [patent_doc_number] => 20060292121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Retroviral vectors including modified envelope escort protein' [patent_app_type] => utility [patent_app_number] => 11/452083 [patent_app_country] => US [patent_app_date] => 2006-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8961 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292121.pdf [firstpage_image] =>[orig_patent_app_number] => 11452083 [rel_patent_id] =>[rel_patent_doc_number] =>)